pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

Vivus LLC

updated 2mo ago

Vivus is a small pharmaceutical company headquartered in Campbell, California that specializes in obesity, sleep, and sexual health. Vivus developed Avanafil, an erectile dysfunction drug that has completed Phase 3 clinical trials. The drug has been approved for use by the Food and Drug Administration, and is sold under the trademark name Stendra. Stendra is the first and only oral erectile dysfunction treatment approved to be taken approximately 15 minutes before sexual activity.

community read0 votes

🐶 often sniffed alongside

top 6
  • tagApproval44 co-mentions · 22 sources
  • drugQSYMIA44 co-mentions · 22 sources
  • tagSmall Molecule22 co-mentions · 22 sources
  • drug(phentermine hydrochloride + topiramate) ER22 co-mentions · 22 sources
  • drugphentermine hydrochloride22 co-mentions · 22 sources
  • drugphentermine hydrochloride ODT22 co-mentions · 22 sources
pipeline
4
marketed
3
phase 3
0
catalysts ytd
1
approvals ytd
1
recalls ytd
0

Pipeline(4)

pipeline depth4 products
Marketed: 3Unknown: 1
3Marketed1Unknown
Marketed
(phentermine hydrochloride + topiramate) ER
Obesity
Marketed
avanafil
Erectile Dysfunction
Marketed
pancrelipase DR
Exocrine Pancreatic Insufficiency
drug
QSYMIA

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Active trials

  • phase2A Study of Carmustine With and Without Ethanol in Subjects With Lymphomarecruitingn=49
  • phase4A Study of VI-0521 on Ambulatory Blood Pressure (ABPM) in Overweight or Obese Subjectscompletedn=565
🐶 Hiring Signal
No open roles indexed yet — view Vivus LLC jobs →

News

no news has mentioned this company yet
identifiers
source
globaldata
top tags
Obesity1
mentioned in
0news items
entity-linker matched
Data sources
openFDA
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?